Table 5 Indication for biopsy in malignant cases (n = 133)
Indication for biopsy in malignant cases | Reason for US/FNA not impacting on decision-making |
|---|---|
Clinical suspicion (n = 68) | No US performed (n = 63) |
US inconclusive/not suspicious (n = 5) | |
No FNA performed (n = 19) | |
FNA results inconclusive/not suspicious/not awaited (n = 49) | |
Clinical and US suspicion (n = 61) | No FNA performed (n = 5) |
FNA results inconclusive/not suspicious/not awaited (n = 56) | |
Clinical suspicion and FNA C5 (n = 2) | No US performed (n = 2) |
FNA C3 result (n = 1)a | No US performed (n = 1) |
Clinical and US suspicion, FNA C5 (n = 1) | Not applicable |